✦ LIBER ✦

Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancer

✍ Scribed by M. Bontenbal; A. S. Th. Planting; C. J. Rodenburg; A. Dees; J. Verweij; C. C. M. Bartels; J. Alexieva-Figusch; W. L. J. Putten; J. G. M. Klijn

Publisher: Springer US
Year: 1992
Tongue: English
Weight: 459 KB
Volume: 21
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf01836959

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line chemotherapy with long-term

Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancer

✍ M. Bontenbal; A. S. Th. Planting; J. Verweij; R. Wit; W. H. J. Kruit; G. Stoter; 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 377 KB

Prednimustine combined with mitoxantrone

Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer

✍ Hellmut Samonigg; Herbert Stöger; Anne-Katrin Kasparek; Marianne Schmid; Johann 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 468 KB

Megestrol acetate plus alpha 2a interfer

Megestrol acetate plus alpha 2a interferon as second line therapy for postmenopausal patients with advanced breast cancer: Results of a multicentric phase II trial

✍ Domenico Amoroso; Francesco Boccardo; Monica Balestrero; Loredana Miglietta; Ful 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 359 KB